Heron Therapeutics Inc

+0.07 (+2.26%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)324.87M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$24.47 Million
Adjusted EPS-$0.50
See more estimates
10-Day MA$3.43
50-Day MA$4.87
200-Day MA$8.47
See more pivots

Heron Therapeutics Inc Stock, NASDAQ:HRTX

4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 302


Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.